Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti-Alzheimer's agents

IF 4.3 3区 医学 Q2 CHEMISTRY, MEDICINAL Archiv der Pharmazie Pub Date : 2024-07-05 DOI:10.1002/ardp.202400067
Demokrat Nuha, Asaf Evrim Evren, Begüm Nurpelin Sağlık Özkan, Nalan Gundogdu-Karaburun, Ahmet Çagri Karaburun
{"title":"Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti-Alzheimer's agents","authors":"Demokrat Nuha,&nbsp;Asaf Evrim Evren,&nbsp;Begüm Nurpelin Sağlık Özkan,&nbsp;Nalan Gundogdu-Karaburun,&nbsp;Ahmet Çagri Karaburun","doi":"10.1002/ardp.202400067","DOIUrl":null,"url":null,"abstract":"<p>The development of targeted phthalazine-1,4-dione acetylcholinesterase (AChE) inhibitors for treating Alzheimer's disease involved the synthesis of 32 compounds via a multistage process. Various analytical techniques confirmed the compounds' identities. Thirteen compounds were found to inhibit AChE by more than 50% without affecting butyrylcholinesterase (BChE). Among these, three compounds, <b>8m</b>, <b>8n</b>, and <b>8p</b>, exhibited extraordinary activity similar to donepezil, a reference AChE inhibitor. During enzyme kinetic studies, compound <b>8n</b>, displaying the highest AChE inhibitory activity, underwent evaluation at three concentrations (2 × IC<sub>50</sub>, IC<sub>50</sub>, and IC<sub>50</sub>/2). Lineweaver–Burk plots indicated mixed inhibition activity for compound <b>8n</b> against AChE, suggesting a combination of competitive and noncompetitive characteristics. Additionally, effective derivatives <b>8m</b>, <b>8n</b>, and <b>8p</b> exhibited high blood–brain barrier (BBB) permeability in in vitro parallel artificial membrane permeability assay tests. Molecular docking studies revealed that these compounds bind to the enzyme's active site residues in a position similar to donepezil. Molecular dynamic simulations confirmed the stability of the protein–ligand system, and the chemical reactivity characteristics of the compounds were investigated using density functional theory. The compounds' wide energy gaps suggest stability and therapeutic potential. This research represents a significant step toward finding a potential cure for Alzheimer's disease. However, further research and testing are required to determine the compounds' safety and efficacy. The unique structure of phthalazine derivatives makes them suitable for various biological activities, and these compounds show promise for developing effective drugs for treating Alzheimer's disease. Overall, the development of these targeted compounds is a crucial advancement in the search for an effective treatment for Alzheimer's disease.</p>","PeriodicalId":128,"journal":{"name":"Archiv der Pharmazie","volume":"357 10","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ardp.202400067","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archiv der Pharmazie","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ardp.202400067","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

The development of targeted phthalazine-1,4-dione acetylcholinesterase (AChE) inhibitors for treating Alzheimer's disease involved the synthesis of 32 compounds via a multistage process. Various analytical techniques confirmed the compounds' identities. Thirteen compounds were found to inhibit AChE by more than 50% without affecting butyrylcholinesterase (BChE). Among these, three compounds, 8m, 8n, and 8p, exhibited extraordinary activity similar to donepezil, a reference AChE inhibitor. During enzyme kinetic studies, compound 8n, displaying the highest AChE inhibitory activity, underwent evaluation at three concentrations (2 × IC50, IC50, and IC50/2). Lineweaver–Burk plots indicated mixed inhibition activity for compound 8n against AChE, suggesting a combination of competitive and noncompetitive characteristics. Additionally, effective derivatives 8m, 8n, and 8p exhibited high blood–brain barrier (BBB) permeability in in vitro parallel artificial membrane permeability assay tests. Molecular docking studies revealed that these compounds bind to the enzyme's active site residues in a position similar to donepezil. Molecular dynamic simulations confirmed the stability of the protein–ligand system, and the chemical reactivity characteristics of the compounds were investigated using density functional theory. The compounds' wide energy gaps suggest stability and therapeutic potential. This research represents a significant step toward finding a potential cure for Alzheimer's disease. However, further research and testing are required to determine the compounds' safety and efficacy. The unique structure of phthalazine derivatives makes them suitable for various biological activities, and these compounds show promise for developing effective drugs for treating Alzheimer's disease. Overall, the development of these targeted compounds is a crucial advancement in the search for an effective treatment for Alzheimer's disease.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
作为抗阿尔茨海默氏症药物的新型酞嗪-1,4-二酮衍生物的设计、合成、生物学评价和分子模型模拟。
开发用于治疗阿尔茨海默病的酞嗪-1,4-二酮乙酰胆碱酯酶(AChE)靶向抑制剂需要通过多阶段过程合成 32 种化合物。各种分析技术确认了这些化合物的身份。研究发现,有 13 种化合物对 AChE 的抑制率超过 50%,且不影响丁酰胆碱酯酶(BChE)。其中,8m、8n 和 8p 这三种化合物表现出了与 AChE 抑制剂多奈哌齐相似的非凡活性。在酶动力学研究中,化合物 8n 显示出最高的 AChE 抑制活性,在三个浓度(2 × IC50、IC50 和 IC50/2)下进行了评估。Lineweaver-Burk 图显示化合物 8n 对 AChE 具有混合抑制活性,表明其兼具竞争性和非竞争性特征。此外,有效衍生物 8m、8n 和 8p 在体外平行人工膜渗透性试验中表现出较高的血脑屏障(BBB)渗透性。分子对接研究显示,这些化合物与酶活性位点残基的结合位置与多奈哌齐相似。分子动力学模拟证实了蛋白质配体系统的稳定性,并利用密度泛函理论研究了这些化合物的化学反应特性。化合物的宽能隙表明其具有稳定性和治疗潜力。这项研究是朝着找到阿尔茨海默病潜在治疗方法迈出的重要一步。不过,要确定这些化合物的安全性和有效性,还需要进一步的研究和测试。酞嗪衍生物的独特结构使其适用于各种生物活动,这些化合物有望开发出治疗阿尔茨海默病的有效药物。总之,这些靶向化合物的开发是寻找阿尔茨海默病有效治疗方法的重要进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Archiv der Pharmazie
Archiv der Pharmazie 医学-化学综合
CiteScore
7.90
自引率
5.90%
发文量
176
审稿时长
3.0 months
期刊介绍: Archiv der Pharmazie - Chemistry in Life Sciences is an international journal devoted to research and development in all fields of pharmaceutical and medicinal chemistry. Emphasis is put on papers combining synthetic organic chemistry, structural biology, molecular modelling, bioorganic chemistry, natural products chemistry, biochemistry or analytical methods with pharmaceutical or medicinal aspects such as biological activity. The focus of this journal is put on original research papers, but other scientifically valuable contributions (e.g. reviews, minireviews, highlights, symposia contributions, discussions, and essays) are also welcome.
期刊最新文献
Design and synthesis of pyridazin-4-one derivatives as necroptosis inhibitors. Design, synthesis and biological evaluation of (E)-kojyl-styryl-sulfones: Novel recilisib hybrids as promising radioprotectors. Sumac liposomes/mesenchymal stem cells fight methotrexate-induced nephrotoxicity in rats via regulating Nrf-2/Keap-1/HO-1 and apoptotic signaling pathways. Synthesis of hydroxytyrosol analogs with enhanced antioxidant and cytostatic properties against MG-63 human osteoblast-like cells and their potential implications for bone health. Secondary metabolite profiles and anti-SARS-CoV-2 activity of ethanolic extracts from nine genotypes of Cannabis sativa L.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1